BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33273797)

  • 1. Crystalline Nephropathy due to APRT Deficiency: A Preventable Cause of Renal and Renal Allograft Failure.
    Rajput P; Virani ZA; Shah BV
    Indian J Nephrol; 2020; 30(4):290-292. PubMed ID: 33273797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.
    Bollée G; Cochat P; Daudon M
    Can J Kidney Health Dis; 2015; 2():31. PubMed ID: 26380104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.
    Zaidan M; Palsson R; Merieau E; Cornec-Le Gall E; Garstka A; Maggiore U; Deteix P; Battista M; Gagné ER; Ceballos-Picot I; Duong Van Huyen JP; Legendre C; Daudon M; Edvardsson VO; Knebelmann B
    Am J Transplant; 2014 Nov; 14(11):2623-32. PubMed ID: 25307253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic tubulointerstitial kidney disease in untreated adenine phosphoribosyl transferase (APRT) deficiency: A case report
.
    Cochran B; Kovačíková T; Hodaňová K; Živná M; Hnízda A; Niehaus AG; Bonnecaze A; Balasubraminiam G; Ceballos-Picot I; Hawfield A; Kidd K; Kmoch S; Bleyer AJ
    Clin Nephrol; 2018 Oct; 90(4):296-301. PubMed ID: 30106368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation.
    Micheli V; Massarino F; Jacomelli G; Bertelli M; Corradi MR; Guerrini A; Cucchiara A; Ravetti JL; Negretti L; Cannella G
    NDT Plus; 2010 Oct; 3(5):436-8. PubMed ID: 25984046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2,8-dihydroxyadenine nephrolithiasis: from diagnosis to therapy].
    Bouzidi H; Lacour B; Daudon M
    Ann Biol Clin (Paris); 2007; 65(6):585-92. PubMed ID: 18039602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenine phosphoribosyl transferase deficiency leads to renal allograft dysfunction in kidney transplant recipients: a systematic review.
    Rashid I; Verma A; Tiwari P; D'Cruz S
    J Bras Nefrol; 2022; 44(3):403-416. PubMed ID: 35635787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,8-Dihydroxyadenine urolithiasis: a not so rare inborn error of purine metabolism.
    Ceballos-Picot I; Daudon M; Harambat J; Bensman A; Knebelmann B; Bollée G
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):241-52. PubMed ID: 24940675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of 2,8-dihydroxyadenine Crystalline Nephropathy in a Kidney Transplant Recipient: A Case Report and Literature Review.
    Cheng Y; Guo L; Wang M; Chen J; Wang R
    Intern Med; 2021 Aug; 60(16):2651-2657. PubMed ID: 33678741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,8-Dihydroxyadenine Nephropathy Identified as Cause of End-Stage Renal Disease After Renal Transplant.
    George SA; Al-Rushaidan S; Francis I; Soonowala D; Nampoory MRN
    Exp Clin Transplant; 2017 Oct; 15(5):574-577. PubMed ID: 27447713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenine phosphoribosyl transferase (APRT) deficiency and a novel sequence variant in APRT with phenotypic diversity and a literature review.
    Leow EH; Chong SL; Tan ES; Koh AL; Cham BWM; Yap CJY; Ng YH
    Nephrology (Carlton); 2023 Dec; 28(12):649-654. PubMed ID: 37619970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.
    Edvardsson VO; Runolfsdottir HL; Thorsteinsdottir UA; Sch Agustsdottir IM; Oddsdottir GS; Eiriksson F; Goldfarb DS; Thorsteinsdottir M; Palsson R
    Eur J Intern Med; 2018 Feb; 48():75-79. PubMed ID: 29241594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.
    Nasr SH; Sethi S; Cornell LD; Milliner DS; Boelkins M; Broviac J; Fidler ME
    Nephrol Dial Transplant; 2010 Jun; 25(6):1909-15. PubMed ID: 20064951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2,8-dihydroxyadenine urolithiasis: case report and literature review].
    Arancio M; Ranzoni S; Delsignore A; Landi G; Maffei N; Marcato M; Mina A; Martinengo C
    Urologia; 2011; 78(4):305-9. PubMed ID: 21553389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of adenine phosphoribosyltransferase (APRT) deficiency discovered by urine examination].
    Konishi N; Takeshita K; Yasui H
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1191-5. PubMed ID: 7815752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenine phosphoribosyltransferase deficiency.
    Bollée G; Harambat J; Bensman A; Knebelmann B; Daudon M; Ceballos-Picot I
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1521-7. PubMed ID: 22700886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation.
    Nanmoku K; Kurosawa A; Shinzato T; Shimizu T; Kimura T; Yagisawa T
    Intern Med; 2017; 56(11):1387-1391. PubMed ID: 28566603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of 2,8-DHA crystalline nephropathy caused by adenine phosphoribosyltransferase deficiency: diagnosis and treatment.
    Kunou M; Yamaguchi M; Takahashi H; Kimura Y; Watanabe N; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Katsuno T; Banno S; Ito Y; Ishimoto T
    CEN Case Rep; 2023 Aug; 12(3):329-334. PubMed ID: 36576711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency, carriers and healthy control subjects.
    Runolfsdottir HL; Palsson R; Thorsteinsdottir UA; Indridason OS; Agustsdottir IMS; Oddsdottir GS; Thorsteinsdottir M; Edvardsson VO
    Mol Genet Metab; 2019; 128(1-2):144-150. PubMed ID: 31378568
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.